Literature DB >> 15208593

Incorrect allergy injections: allergists' experiences and recommendations for prevention.

Donald W Aaronson1, Tejal K Gandhi.   

Abstract

There are several reports of fatalities caused by allergen immunotherapy and skin testing. Patients have been reported who have received incorrect allergy injections. These could put them at risk for anaphylactic reaction and a possible fatality. We performed a survey to determine allergists' experiences with incorrect injections and to identify opportunities for prevention. This study was endorsed by the American Academy of Allergy, Asthma and Immunology and the Joint Council of Allergy, Asthma and Immunology. We conducted an e-mail survey of 1717 allergists, asking whether they knew of an incorrect injection administered within the last 5 years in their offices. An incorrect injection is an injection given to the wrong patient or a correct patient receiving an injection of an incorrect dose. Fifty-eight percent of responders reported an event in which a patient had received an injection meant for another patient. Seventy-four percent of responders reported that patients had received an incorrect amount of vaccine. The effect on patients ranged from local reactions to one fatality. Specific reasons given for the incorrect injections were patient name similar to that of another patient with incorrect name check and nurse error resulting in an incorrect dose. We conclude that allergy injections are a potential safety concern. There are a variety of prevention strategies that could be implemented to reduce or eliminate this risk, such as improved nurse training in the administration of allergy injections and compliance with the recommendations in the "Allergen Immunotherapy: A Practice Parameter" for use of patient-specific vials, standardized dosage sheets, and implementation of triple-checking of identity to make sure the correct patient is receiving the correct injection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15208593     DOI: 10.1016/j.jaci.2004.01.756

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

Review 1.  New insights in sublingual immunotherapy.

Authors:  Giovanni Passalacqua; Laura Guerra; Enrico Compalati; Federica Fumagalli; Arianna Cirillo; Giorgio Walter Canonica
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

Review 2.  Allergen injection immunotherapy for seasonal allergic rhinitis.

Authors:  M A Calderon; B Alves; M Jacobson; B Hurwitz; A Sheikh; S Durham
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 3.  Immunotherapy safety: what have we learned from surveillance surveys?

Authors:  Jennifer A Kannan; Tolly G Epstein
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

4.  Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement.

Authors:  Marek L Kowalski; Ignacio Ansotegui; Werner Aberer; Mona Al-Ahmad; Mubeccel Akdis; Barbara K Ballmer-Weber; Kirsten Beyer; Miguel Blanca; Simon Brown; Chaweewan Bunnag; Arnaldo Capriles Hulett; Mariana Castells; Hiok Hee Chng; Frederic De Blay; Motohiro Ebisawa; Stanley Fineman; David B K Golden; Tari Haahtela; Michael Kaliner; Connie Katelaris; Bee Wah Lee; Joanna Makowska; Ulrich Muller; Joaquim Mullol; John Oppenheimer; Hae-Sim Park; James Parkerson; Giovanni Passalacqua; Ruby Pawankar; Harald Renz; Franziska Rueff; Mario Sanchez-Borges; Joaquin Sastre; Glenis Scadding; Scott Sicherer; Pongsakorn Tantilipikorn; James Tracy; Vera van Kempen; Barbara Bohle; G Walter Canonica; Luis Caraballo; Maximiliano Gomez; Komei Ito; Erika Jensen-Jarolim; Mark Larche; Giovanni Melioli; Lars K Poulsen; Rudolf Valenta; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2016-10-12       Impact factor: 4.084

5.  Update on allergy immunotherapy.

Authors:  William Davidson; Sean Lucas; Larry Borish
Journal:  Allergy Asthma Clin Immunol       Date:  2005-12-15       Impact factor: 3.406

Review 6.  Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.

Authors:  Giovanni Passalacqua; Giorgio Walter Canonica; Diego Bagnasco
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

7.  A 5-year study of systemic reactions using both shared and patient-specific vaccines.

Authors:  Julian Melamed; Ami Mehra; Angela Ahuja-Malik
Journal:  Allergy Rhinol (Providence)       Date:  2013-01

Review 8.  Allergen-specific immunotherapy in pediatric allergic asthma.

Authors:  Ayfer Yukselen
Journal:  Asia Pac Allergy       Date:  2016-07-28

9.  Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.

Authors:  Cindy M A de Bot; Heleen Moed; Marjolein Y Berger; Esther Röder; Hans de Groot; Johan C de Jongste; Roy Gerth van Wijk; Johannes C van der Wouden
Journal:  BMC Fam Pract       Date:  2008-10-20       Impact factor: 2.497

Review 10.  Allergen immunotherapy in asthma; what is new?

Authors:  Giovanni Passalacqua; Anthi Rogkakou; Marcello Mincarini; Giorgio Walter Canonica
Journal:  Asthma Res Pract       Date:  2015-07-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.